Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026

Go back to Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
(NASDAQ: SPRB) Delayed: 49.99 -3.71 (6.91%)
Previous Close $53.70    52 Week High
Open $54.05    52 Week Low
Day High $54.98    P/E N/A 
Day Low $49.23    EPS
Volume 140,922